Your browser doesn't support javascript.
loading
A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy.
Oda, Shannon K; Anderson, Kristin G; Ravikumar, Pranali; Bonson, Patrick; Garcia, Nicolas M; Jenkins, Cody M; Zhuang, Summer; Daman, Andrew W; Chiu, Edison Y; Bates, Breanna M; Greenberg, Philip D.
Afiliação
  • Oda SK; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Anderson KG; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Ravikumar P; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Bonson P; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Garcia NM; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Jenkins CM; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Zhuang S; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Daman AW; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Chiu EY; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Bates BM; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Greenberg PD; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA.
J Exp Med ; 217(12)2020 12 07.
Article em En | MEDLINE | ID: mdl-32860705
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Linfócitos T / Imunoterapia Adotiva / Receptor fas / Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Linfócitos T / Imunoterapia Adotiva / Receptor fas / Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral Idioma: En Ano de publicação: 2020 Tipo de documento: Article